Mezim forte tab. p / o # 20

Film-coated tablets.

The drug compensates for the insufficiency of the exocrine function of the pancreas.

The enzymes lipase, amylase and protease, which are part of pancreatin, facilitate the digestion of fats, carbohydrates and proteins, which contributes to their more complete absorption in the small intestine.

Name ENG

MEZYM FORTE

Clinical and pharmacological group

Enzyme preparation

ATX code

A09AA02 (Multienzymes (lipase, protease etc.))

Dosage

Pancreatin with minimal enzymatic activity: lipases 3500 U Ph.Eur

amylase 4200 U Ph.Eur

proteases 250 U Ph.Eur

Structure

1 tablet contains: Active substances: pancreatin with minimal enzymatic activity: lipase 3500 U Ph.Eur

amylase 4200 U Ph.Eur

proteases 250 U Ph.Eur.

Excipients: microcrystalline cellulose, sodium carboxymethyl starch (type A), colloidal silicon dioxide, magnesium stearate.

Shell composition: talc, hypromellose, azorubin varnish (E122), simethicone emulsion 30% (dry weight), polyacrylate dispersion 30% (dry weight), titanium dioxide (E171), macrogol 6000.

Indications

Substitution therapy for exocrine insufficiency of pancreatic functions (including chronic pancreatitis, cystic fibrosis)

chronic inflammatory-dystrophic diseases of the stomach, intestines, liver, gallbladder

conditions after resection or irradiation of the digestive tract, accompanied by impaired digestion of food, flatulence, diarrhea (as part of combination therapy)

functional gastrointestinal tract disorder (with intestinal infectious diseases, irritable bowel syndrome, etc.)

to improve the digestion of food in patients with normal gastrointestinal tract function in case of nutritional errors

preparation for X-ray and ultrasound examinations of the abdominal organs.

INN / Active ingredient

Pancreatin

Storage conditions and periods

At a temperature not higher than 25 degrees.

Expiration date: 3 years

Contraindications

Acute pancreatitis

exacerbation of chronic pancreatitis

hypersensitivity to pancreatin or other components of the drug

hereditary galactose intolerance, lactase deficiency or glucose-galactose malabsorption syndrome

children under 3 years of age (indivisible dosage form).

Specifications

Category

Enzymes

Scope of the drug

Gastrointestinal tract

Release form

Tablet

Manufacturer country

Germany

Package quantity, pcs

twenty

Scope of application

Gastroenterology

Way of introduction

Through the mouth

Vacation conditions

Without recipe

Brand name

Berlin-Chemie

The amount of the dosage form in the primary package

20 pcs.

Primary packaging type

Blister

Type of consumer packaging

Pack of cardboard

Pharmaco-therapeutic group

Digestive Enzyme Remedy

Anatomical and therapeutic characteristics

A09AA02 Polyenzyme preparations (lipase + protease, etc.)

Dosage form

Film-coated tablets

Expiration date in days

1095

Package weight, g

ten

Mode of application

:

The dose is determined individually, depending on the degree of indigestion.

< br> Adults: 1-2 tab.

before meals, without chewing and drinking water.

If necessary, additionally during meals, take another 1-4 tab.

< br> In children: the drug is used as directed by a doctor.

< br> < br> The duration of treatment can vary from several days (if the digestive process is disturbed due to dietary errors) to several months or years (if constant substitution therapy is necessary).

Dosage (volume) of the substance in the preparation

:

lipase 3500 U Ph.Eur, amylase 4200 U Ph.Eur, proteases 250 U Ph.Eur